Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum

Detalles Bibliográficos
Autores principales: Dong, Jiang-Kai, Lei, Hui-Min, Liang, Qian, Tang, Ya-Bin, Zhou, Ye, Wang, Yang, Zhang, Shengzhe, Li, Wen-Bin, Tong, Yunguang, Zhuang, Guanglei, Zhang, Liang, Chen, Hong-Zhuan, Zhu, Liang, Shen, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914359/
https://www.ncbi.nlm.nih.gov/pubmed/33664874
http://dx.doi.org/10.7150/thno.58558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914359/
https://www.ncbi.nlm.nih.gov/pubmed/33664874
http://dx.doi.org/10.7150/thno.58558

Ejemplares similares